Bentley Experts Say New Business Model Could Help Save Biotech IPOs
January 24, 2014
During the biotech IPO boom in 2000, a lot of people made money; but very few products ever made it into the hands of consumers. Research by Bentley University’s Laura McNamee and Fred Ledley credits the problem to poor business models that have a glaring gap between science and business.
